Jude Chuks Azu

Pharmacogenomics and Neuroimaging for Predicting Treatment Response and Relapse in Co-Occurring Mental Illness and Substance Use Disorders: A Systematic Evidence Review

Obianuju M. Akujuobi, Jude Chuks Azu, Soky O. Uzoigwe, Christiana C. Ezeihekaibee & Osamuyimen M. Eronmwon · International Neuropsychiatric Disease Journal · 2026

Background: Co-occurring mental illness and substance use disorders (SUDs) are associated with high clinical complexity, heterogeneous treatment response and recurrent relapse. Pharmacogenomic and neuroimaging biomarkers may complement conventional clinical predictors, but the ex...

Open access Research Article 10.9734/indj/2026/v23i5586

Barriers to Implementing Multimodal Precision Psychiatry in the Treatment of Opioid Use Disorder in the United States: A Critical Narrative Review

Obianuju M. Akujuobi, Jude Chuks Azu, Osamuyimen M. Eronmwon, Christiana C. Ezeihekaibee & Uche S. Chukwuemeka · International Neuropsychiatric Disease Journal · 2026

Precision psychiatry proposes that the combination of genomic, neuroimaging, peripheral biological, digital and health-record data will permit treatment to be matched to individual patients rather than to diagnostic categories. Opioid use disorder in the United States has been ad...

Open access Research Article 10.9734/indj/2026/v23i5584